Medication info
Telmisartan Hydrochlorothiazide Tablets 40/12.5 mg (Telmisartan, Hydrochlorothiazide)

Telmisartan Hydrochlorothiazide Tablets 40/12.5 mg (Telmisartan, Hydrochlorothiazide)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Daewoo Pharmaceutical Co., Ltd.
Appearance
Oval-shaped tablet consisting of two layers: white/pink with possible pink speckles on the white layer.
Packaging
30 tablets/box [10 tablets/Alu-Alu x 3]
Approval status
Active

MFDS item code 201604631 · Approved 2016.07.27 · Insurance code 649606340

Summary

Main use
Treatment of essential hypertension not adequately controlled with telmisartan alone
Who takes it
Adults · Children
Adult dose
Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a beverage, with or without food. Before switching to this medicine, which contains fixed doses of each component, it is recommended to adjust the dose of each component individually. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given concomitantly as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment Administer this medicine with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine daily. Do not administer this medicine to patients with severe hepatic impairment (see Precautions for Use, 2.). Thiazide diuretics should be administered with caution to patients with impaired liver function. Elderly patients No dose adjustment is necessary.
Child dose
Under 18 years of age: The safety and efficacy of this medicine have not been established.

Ingredients

Manufacturer
Daewoo Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not adequately controlled with telmisartan alone

  • Essential hypertension
View approved original text

This medication is used for the treatment of essential hypertension, effectively managing blood pressure when telmisartan alone is insufficient. It helps to improve blood pressure stability.

How to take

Adult dose

Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a beverage, with or without food. Before switching to this medicine, which contains fixed doses of each component, it is recommended to adjust the dose of each component individually. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given concomitantly as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment Administer this medicine with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine daily. Do not administer this medicine to patients with severe hepatic impairment (see Precautions for Use, 2.). Thiazide diuretics should be administered with caution to patients with impaired liver function. Elderly patients No dose adjustment is necessary.

Child dose

Under 18 years of age: The safety and efficacy of this medicine have not been established.

Precautions

This medication should not be used by women who are pregnant, especially during the second and third trimesters, as it can cause serious harm to the fetus. Patients allergic to any of the components or with specific liver or kidney diseases should not take this medicine. Elderly patients and those with elevated potassium levels or liver impairments should use this medication with caution, as there may be an increased risk of skin cancer due to sun exposure. During treatment, side effects such as dizziness, hypotension, and electrolyte imbalances may occur, and if these symptoms appear, immediate consultation with a healthcare professional is necessary. Interactions may occur if taken with other antihypertensives, certain diuretics, lithium, non-steroidal anti-inflammatory drugs, etc., so it is essential to inform the prescribing doctor and undergo regular blood pressure and blood tests. It is not administered to pregnant or breastfeeding women, and its safety in children has not been established, thus it is not recommended. In case of overdose, hypotension, electrolyte disturbances, and dehydration may occur, requiring immediate emergency treatment. Store this medication in a tightly sealed container and away from direct sunlight, and it is best to take the medication directly from its packaging.

Side effects

  • Bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorders
Show 120 more
  • dizziness
  • syncope
  • paresthesia
  • visual impairment
  • blurriness
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • pneumonia
  • pulmonary edema
  • diarrhea
  • dry mouth
  • bloating
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • abnormal liver function
  • liver disease
  • angioedema
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • urticaria
  • back pain
  • muscle cramps
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • elevated blood uric acid
  • increased blood creatinine
  • increased blood creatine kinase enzyme
  • elevated liver enzymes
  • upper respiratory infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • cough
  • dry mouth
  • abdominal discomfort
  • eczema
  • drug rash
  • toxic skin rash
  • bone pain
  • kidney dysfunction
  • weakness
  • elevated blood creatine kinase enzyme
  • elevated blood uric acid
  • jaundice
  • bile duct obstruction
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • systemic lupus erythematosus
  • acute renal failure
  • diabetes
  • weakness
  • fever
  • nausea
  • gastrointestinal bleeding
  • esophagitis
  • headache
  • tremors
  • facial flushing
  • malaise
  • fatigue
  • weight loss
  • proteinuria
  • itching
  • myalgia
  • floating sensation
  • lip and hand tremors
  • sensory hypersensitivity
  • decreased vision
  • hypotension
  • tachycardia
  • bradycardia
  • angioedema
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • hypersensitivity
  • sialadenitis
  • non-melanoma skin cancer
  • thrombocytopenia
  • hypomagnesemia
  • hyperlipidemia
  • hyperglycemia
  • hypercalcemia
  • hypochloremic metabolic alkalosis
  • pneumonia
  • acute respiratory distress syndrome
  • pancreatitis
  • thrombocytopenia
  • thrombocytopenic purpura
  • acute myopia
  • closed-angle glaucoma
  • choroidal effusion
  • acute respiratory distress syndrome
  • intestinal vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Oval-shaped tablet consisting of two layers: white/pink with possible pink speckles on the white layer.

Package unit

30 tablets/box [10 tablets/Alu-Alu x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.